BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19180989)

  • 1. Development and validation of a multi-dose neutropenic rat thigh infection model using real-time monitoring of Staphylococcus aureus growth in vivo.
    Zhang H; Kalkeri G; Mani N; Grossman TH
    In Vivo; 2008; 22(6):667-72. PubMed ID: 19180989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection.
    Xiao XM; Xiao YH
    Acta Pharmacol Sin; 2008 Oct; 29(10):1253-60. PubMed ID: 18817632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model.
    Barnea Y; Carmeli Y; Kuzmenko B; Navon-Venezia S
    J Antimicrob Chemother; 2008 Dec; 62(6):1339-43. PubMed ID: 18799473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis.
    Cirioni O; Ghiselli R; Orlando F; Silvestri C; De Luca S; Salzano AM; Mocchegiani F; Saba V; Scalise G; Scaloni A; Giacometti A
    Crit Care Med; 2008 Sep; 36(9):2629-33. PubMed ID: 18679116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model.
    Hegde SS; Difuntorum S; Skinner R; Trumbull J; Krause KM
    J Antimicrob Chemother; 2009 Apr; 63(4):763-6. PubMed ID: 19155225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
    Keeling WB; Myers AR; Stone PA; Heller L; Widen R; Back MR; Johnson BL; Bandyk DF; Shames ML
    J Surg Res; 2009 Dec; 157(2):223-6. PubMed ID: 19560786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases.
    Zuluaga AF; Salazar BE; Rodriguez CA; Zapata AX; Agudelo M; Vesga O
    BMC Infect Dis; 2006 Mar; 6():55. PubMed ID: 16545113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats.
    Kalteis T; Beckmann J; Schröder HJ; Handel M; Grifka J; Lehn N; Lerch K
    Acta Orthop; 2006 Apr; 77(2):315-9. PubMed ID: 16752296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection.
    Orlando F; Ghiselli R; Cirioni O; Minardi D; Tomasinsig L; Mocchegiani F; Silvestri C; Skerlavaj B; Riva A; Muzzonigro G; Saba V; Scalise G; Zanetti M; Giacometti A
    Peptides; 2008 Jul; 29(7):1118-23. PubMed ID: 18430491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose infectivity of Staphylococcus aureus (SMH strain) in traumatized rat tibiae provides a model for studying early events in contaminated bone injuries.
    Buxton TB; Travis MT; O'Shea KJ; McPherson JC; Harvey SB; Plowman KM; Walsh DS
    Comp Med; 2005 Apr; 55(2):123-8. PubMed ID: 15884772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of implant-associated infections with moxifloxacin: an animal study.
    Kalteis T; Beckmann J; Schröder HJ; Schaumburger J; Linde HJ; Lerch K; Lehn N
    Int J Antimicrob Agents; 2006 May; 27(5):444-8. PubMed ID: 16621461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
    Deresinski S
    Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection.
    Rocchetta HL; Boylan CJ; Foley JW; Iversen PW; LeTourneau DL; McMillian CL; Contag PR; Jenkins DE; Parr TR
    Antimicrob Agents Chemother; 2001 Jan; 45(1):129-37. PubMed ID: 11120955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis.
    Guo Y; Li J; Hagström E; Ny T
    Arthritis Rheum; 2008 Mar; 58(3):764-72. PubMed ID: 18311818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: Daptomycin for the treatment of gram-positive infections in neutropenic cancer patients.
    Rolston KV
    Clin Adv Hematol Oncol; 2008 Nov; 6(11):815-7. PubMed ID: 19194365
    [No Abstract]   [Full Text] [Related]  

  • 16. Real-time monitoring of bacterial infection in vivo: development of bioluminescent staphylococcal foreign-body and deep-thigh-wound mouse infection models.
    Kuklin NA; Pancari GD; Tobery TW; Cope L; Jackson J; Gill C; Overbye K; Francis KP; Yu J; Montgomery D; Anderson AS; McClements W; Jansen KU
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2740-8. PubMed ID: 12936968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus bloodstream infections: definitions and treatment.
    Corey GR
    Clin Infect Dis; 2009 May; 48 Suppl 4():S254-9. PubMed ID: 19374581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the therapeutic efficacy of linezolid and vancomycin and correlation of serum and tissue malondialdehyde and myeloperoxidase in an experimental mediastinitis model.
    Sacar S; Sacar M; Aybek H; Turgut H; Onem G; Cevahir N; Teke Z; Kaleli I; Guler A; Ucak A; Baltalarli A
    J Surg Res; 2009 Mar; 152(1):89-95. PubMed ID: 18952240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of postoperative spinal implant infection using gentamicin microspheres.
    Stall AC; Becker E; Ludwig SC; Gelb D; Poelstra KA
    Spine (Phila Pa 1976); 2009 Mar; 34(5):479-83. PubMed ID: 19247168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-infection of the cotton rat (Sigmodon hispidus) with Staphylococcus aureus and influenza A virus results in synergistic disease.
    Braun LE; Sutter DE; Eichelberger MC; Pletneva L; Kokai-Kun JF; Blanco JC; Prince GA; Ottolini MG
    Microb Pathog; 2007; 43(5-6):208-16. PubMed ID: 17689046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.